Optimind Pharma (XCNQ:OMND) Change In Payables And Accrued Expense : C$0.07 Mil (TTM As of Nov. 2023)

View and export this data going back to 2022. Start your Free Trial

What is Optimind Pharma Change In Payables And Accrued Expense?

Optimind Pharma's Change In Payables And Accrued Expense for the quarter that ended in Nov. 2023 was C$0.08 Mil. It means Optimind Pharma's Accounts Payable & Accrued Expense increased by C$0.08 Mil from Aug. 2023 to Nov. 2023 .

Optimind Pharma's Change In Payables And Accrued Expense for the fiscal year that ended in Feb. 2023 was C$-0.02 Mil. It means Optimind Pharma's Accounts Payable & Accrued Expense declined by C$0.02 Mil from Feb. 2022 to Feb. 2023 .

Optimind Pharma Change In Payables And Accrued Expense Historical Data

The historical data trend for Optimind Pharma's Change In Payables And Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Optimind Pharma Change In Payables And Accrued Expense Chart

Optimind Pharma Annual Data

Trend

Feb22

Feb23

Change In Payables And Accrued Expense

-0.02

Optimind Pharma Quarterly Data
	Jun21	May22	Aug22	Nov22	Feb23	May23	Aug23	Nov23
Change In Payables And Accrued Expense	Get a 7-Day Free Trial			0.01	0.05	-0.02	-0.05	0.08

Optimind Pharma Change In Payables And Accrued Expense Calculation

Change In Payables And Accrued Expense is the increase or decrease between periods of the Accounts Payable & Accrued Expense. Accrued expenses represent expenses incurred at the end of the reporting period but not yet paid; also called accrued liabilities. The accrued liability is shown under Liabilities section in the balance sheet.

Change In Payables And Accrued Expense for the trailing twelve months (TTM) ended in Nov. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was C$0.07 Mil.

Optimind Pharma Change In Payables And Accrued Expense Related Terms

Thank you for viewing the detailed overview of Optimind Pharma's Change In Payables And Accrued Expense provided by GuruFocus.com. Please click on the following links to see related term pages.

Optimind Pharma (XCNQ:OMND) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Optimind Pharma Corp (XCNQ:OMND) » Definitions » Change In Payables And Accrued Expense

Comparable Companies

Traded in Other Exchanges

N/A

Address

3000 - 77 King Street West, TD Centre, North Tower, PO Box 95, Toronto, ON, CAN, M5K 1G8

Website

https://www.optimindpharma.com

Optimind Pharma Corp is an emerging provider of psychedelic therapies for the masses. It helps people suffering from PTSD, Anxiety, Depression, and other mental illnesses and disabilities by providing ketamine-assisted-treatment and other psychedelic-enhanced-psychotherapy modalities.

Optimind Pharma (XCNQ:OMND) Headlines

No Headlines